Ardelyx to Participate in Jefferies Global Healthcare Conference Fireside Chat

Wednesday, Nov 5, 2025 8:05 am ET1min read
ARDX--

Ardelyx management will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 19, 2025. The company, founded to discover and commercialize innovative medicines, has two commercial products approved in the US: IBSRELA and XPHOZAH, both developed by Ardelyx. A live webcast of the panel presentation and a replay will be available on the Ardelyx website for 30 days following the event.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet